Navigation Links
DeLuca speaks out on entrepreneurialism, tech transfer, and WARF

Interview with DeLuca offers tips for biotech entrepreneurs

MADISON If you stand on your tiptoes and squint, you can almost read the framed documents hanging in the lobby of UW Madison's new $35.6 million biochemistry building.

Patents numbered 3,565,924 and 3,697,559 were issued to Hector Floyd DeLuc......

Full article >>>
'"/>

Source:wistechnology.com By Teresa Esser 07/26/04


Page: 1 2 3

Related biology technology :

1. Innovation expert speaks on the business-IT balancing act
2. NSF officer speaks on the future of journalism and science
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: DeLuca speaks out entrepreneurialism tech transfer and WARF

(Date:7/1/2015)... TRIANGLE PARK, N.C. and ... agricultural research firm AgBiome, and Genective, key developer ... to accelerate the discovery of new generations of ... traits for insect control to counter the realities ... partner with Genective, aligning AgBiome,s unique insect control ...
(Date:7/1/2015)... 1, 2015   Decision Resources Group ... of Otezla are its oral administration, alternative mechanism ... by surveyed rheumatologists. Otezla was the first oral ... of active psoriatic arthritis in the ... care includes conventional oral treatments including disease-modifying antirheumatic ...
(Date:7/1/2015)... ... ... The next-generation sequencing (NGS) clinical market is poised for huge growth as it prepares ... in its new report that the market drivers of this vibrant industry include increased ... diagnostics as part of a molecular diagnostics trend. , The global market is forecast ...
(Date:7/1/2015)... and BANGALORE, India , July ... profiling company that uses next generation sequencing technology to ... Scott A. Storrer as chief executive officer. In ... will be responsible for all strategy, business expansion and ... who has served as Strand,s chairman and CEO since ...
Breaking Biology Technology:AgBiome and Genective collaborate to create novel insect-resistant crops 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 3Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 2Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 3
... OAKS, Calif., June 24, 2011 Amgen (NASDAQ: ... Medicinal Products for Human Use (CHMP) of the European ... that Vectibix® (panitumumab) be approved for use in the ... and in second-line in combination with FOLFIRI in patients ...
... are exposed to light, they blink in a ... at the University of Pennsylvania have shown that ... new insight into this mysterious blinking behavior. ... Drndic,s group, including graduate student Siying Wang and ...
... BioNeutral Group Inc., (OTCBB: BONU.ob) today announced it ... of their revolutionary Cold Sterilant and Cleaning/Odor Products ... selected by New Jersey based T.U.C.S. Cleaning Services ... distribution company, because of the superior effectiveness of ...
Cached Biology Technology:Amgen Receives Positive CHMP Opinion for Vectibix® (Panitumumab) in Combination With Chemotherapy 2Amgen Receives Positive CHMP Opinion for Vectibix® (Panitumumab) in Combination With Chemotherapy 3Amgen Receives Positive CHMP Opinion for Vectibix® (Panitumumab) in Combination With Chemotherapy 4Amgen Receives Positive CHMP Opinion for Vectibix® (Panitumumab) in Combination With Chemotherapy 5Amgen Receives Positive CHMP Opinion for Vectibix® (Panitumumab) in Combination With Chemotherapy 6Amgen Receives Positive CHMP Opinion for Vectibix® (Panitumumab) in Combination With Chemotherapy 7Amgen Receives Positive CHMP Opinion for Vectibix® (Panitumumab) in Combination With Chemotherapy 8Amgen Receives Positive CHMP Opinion for Vectibix® (Panitumumab) in Combination With Chemotherapy 9Amgen Receives Positive CHMP Opinion for Vectibix® (Panitumumab) in Combination With Chemotherapy 10Penn physicists observe 'campfire effect' in blinking nanorod semiconductors 2Penn physicists observe 'campfire effect' in blinking nanorod semiconductors 3BioNeutral Starts Commercial Deployment of Its Ygiene 206 Sterilant and Ogiene Products Within Port Authority Facilities Using T.U.C.S. Cleaning Services 2BioNeutral Starts Commercial Deployment of Its Ygiene 206 Sterilant and Ogiene Products Within Port Authority Facilities Using T.U.C.S. Cleaning Services 3BioNeutral Starts Commercial Deployment of Its Ygiene 206 Sterilant and Ogiene Products Within Port Authority Facilities Using T.U.C.S. Cleaning Services 4
(Date:6/30/2015)... June 30, 2015 To bolster its efforts and ... Corp. announced today the addition of two new team members. ... board advisor and David Raviv will act as ... HYPR Corp.,s commitment to providing the most secure solutions for ... co-founded Layer 7 Technologies, a provider of security and ...
(Date:6/30/2015)... 2015 Genisphere announced Tom ... help further develop Genisphere,s therapeutics capabilities and portfolio. Mr. ... spent much of the last 25 years in leadership ... and Johnson & Johnson. Tom started his career in ... Corporate Finance. He graduated from Dartmouth College with a ...
(Date:6/29/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/zj7h4f/latin_america ) ... Biomedical Sensors Market - Growth, Trends & Forecasts (2014-2020)" ... America Biomedical Sensors market is estimated at $0.65 billion ... period 2014-2020 The near future will bring ... of each individual. These sensors can be set to ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3Latin America Biomedical Sensors Market Report 2015-2020 2
... from the Luxembourg Centre for Systems Biomedicine (LCSB) of ... in the brain can produce a substance that prevents ... assumed that only certain fungi produced itaconic acid. A ... Metabolomics Group at LCSB, and Dr. Alessandro Michelucci has ...
... reporting new outbreaks and the increased spread of Cassava Brown ... virus could cause a 50 percent drop in production of ... income for 300 million Africans. , The "pandemic" of ... been looking to the otherwise resilient cassava plantwhich is also ...
... scientists, writing in the journal Nature Geoscience , have ... an unexpected cooling effect on the world,s climate by making ... on to tiny particles suspended in the air. When the ... It has been known for some decades that the number ...
Cached Biology News:LCSB discovers endogenous antibiotic in the brain 2Scientists alarmed by rapid spread of Brown Streak Disease in cassava 2Scientists alarmed by rapid spread of Brown Streak Disease in cassava 3Scientists alarmed by rapid spread of Brown Streak Disease in cassava 4Organic vapors affect clouds leading to previously unidentified climate cooling 2
Applications: Western blotting ...
Ethylene glycol-bis(2-aminoethyl ether)-N,N,N',N'-tetraacetic acid, Molecular Biology Grade...
Ethylene glycol-bis(2-aminoethyl ether)-N,N,N',N'-tetraacetic acid...
Kit Components: Anti-PARP LumiGLO Chemiluminescent Substrate Immunoblot Blocking Reagent Pyronin Y Reagent Goat Anti-Rabbit IgG, HRP conjugate Double-It Reagent Film Exposure Folders Autor...
Biology Products: